These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Methods for the production of xenogeneic monoclonal antibodies in murine ascites. Weissman D; Parker DJ; Rothstein TL; Marshak-Rothstein A J Immunol; 1985 Aug; 135(2):1001-3. PubMed ID: 4008923 [No Abstract] [Full Text] [Related]
6. Influence of priming and inoculation dose on the production of monoclonal antibodies in two age groups of BALB/c mice. De Deken R; Brandt J; Ceulemans F; Geerts S; Beudeker R Hybridoma; 1994 Feb; 13(1):53-7. PubMed ID: 8200659 [TBL] [Abstract][Full Text] [Related]
7. In vitro immunization for the production of antigen-specific lymphocyte hybridomas. Reading CL Methods Enzymol; 1986; 121():18-27. PubMed ID: 3014268 [No Abstract] [Full Text] [Related]
8. Improved efficiency of hybridoma ascites production by intrasplenic inoculation in mice. Witte PL; Ber R J Natl Cancer Inst; 1983 Mar; 70(3):575-7. PubMed ID: 6339777 [TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro production of monoclonal antibodies. Bioreactors vs immune ascites. Marx U; Merz W Methods Mol Biol; 1995; 45():169-76. PubMed ID: 7550678 [No Abstract] [Full Text] [Related]
10. Development and characterization of mouse hybridomas. Mechetner E Methods Mol Biol; 2007; 378():1-13. PubMed ID: 18605074 [TBL] [Abstract][Full Text] [Related]
11. [Production of hybridomas synthesizing monoclonal antibodies to streptococcal group A polysaccharide]. Pyt'eva EIu; Drobyshevskaia EI Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):35-9. PubMed ID: 3931394 [TBL] [Abstract][Full Text] [Related]
12. Immortalisation of human antibody producing cells. Kalsi JK; Isenberg DA Autoimmunity; 1992; 13(3):249-58. PubMed ID: 1335297 [No Abstract] [Full Text] [Related]
13. Use of electric-field-mediated cell fusion to produce hybridomas secreting monoclonal antibodies. Zhao X Methods Mol Biol; 1995; 45():61-7. PubMed ID: 7550693 [No Abstract] [Full Text] [Related]
14. Process development for hybridoma cells. Harbour C; Barford JP; Low KS Adv Biochem Eng Biotechnol; 1988; 37():1-40. PubMed ID: 3140607 [No Abstract] [Full Text] [Related]
15. An extreme strategy for the production of hybridoma. Golestani R; Pourfathollah AA; Moazzeni SM Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989 [TBL] [Abstract][Full Text] [Related]
16. [Optimal production of murine monoclonal antibodies in ascites of syngeneic mice by a single whole body irradiation]. Witt S; Ziegler B; Klöting I; Nadrowitz R; Schmidt W; Ziegler M Allerg Immunol (Leipz); 1987; 33(4):259-64. PubMed ID: 2964179 [TBL] [Abstract][Full Text] [Related]
18. The effect of postfusion cell density on establishment of hybridomas. Kontseková E; Novák M; Kontsek P; Borecký L; Lesso J Folia Biol (Praha); 1988; 34(1):18-22. PubMed ID: 3391325 [TBL] [Abstract][Full Text] [Related]
19. Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID). Ware CF; Donato NJ; Dorshkind K J Immunol Methods; 1985 Dec; 85(2):353-61. PubMed ID: 4078317 [TBL] [Abstract][Full Text] [Related]
20. [Conditions for forming ascitic tumors in hybridoma cultivation in vivo]. Novokhatskiĭ AS; Malakhova IV; Gaĭdamovich SIa; Mel'nikova EE; Sveshnikova NA Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):13-7. PubMed ID: 3751404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]